Immunology services for the development
of novel medicines

Lamina Propria Lymphocytes (LPL) are a dominant cell population in the gut-associated lymphoid system. Apparently, LPL play an important role in keeping the immunological homeostasis at the large resorptive interface between the gut lumen and the interior of the body. LPL dysfunctions are thought to contribute to the pathology of chronic inflammatory bowel diseases.

Together with clinical institutions of the Heidelberg Medical Centre FOCUS Immunology has established processes that allow to use purified LPL for cell biological and mode-of-action studies.

For further information on our expertise and service offer in LPL biology please us at immunology@focus-cdd.com or contact directly our Head of FOCUS Immunology Dr. Eddy Bruyns at eddy.bruyns@focus-cdd.com.

FOCUS Immunology laboratory is part of the Clinical Research Organisation (CRO) FOCUS-CDD GmbH. FOCUS Immunology provides immunological biomarker services under GLP and non-GLP conditions for the development of novel medicines.